Enigma of Intramuscular Triamcinolone Acetonide (Kenalog®) Efficacy

被引:1
|
作者
Shahinfar, Sheeva [1 ]
Maibach, Howard [2 ]
机构
[1] Texas A&M Univ, Sch Med, 8447 Riverside Pkwy, Bryan, TX 77807 USA
[2] UCSF Dermatol Dept, San Francisco, CA USA
关键词
GLUCOCORTICOID-RECEPTORS; PHARMACOKINETICS; PLASMA; CORTICOSTEROIDS; HYDROCORTISONE; MECHANISMS; CORTISOL; BINDING; DEPOT;
D O I
10.1007/s40262-023-01297-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Triamcinolone acetonide is a glucocorticosteroid used in standard clinical practice for its anti-inflammatory properties. Although it can be given via different routes of administration, the intramuscular route is unique compared with other corticosteroids-its effects remain potent over a longer period of time. We summarize the existing literature on the pharmacokinetic and pharmacodynamic mechanisms of intramuscular triamcinolone acetonide (Kenalog(& REG;)). The fascinating nature of the purported efficacy of triamcinolone acetonide may be attributed to differing binding mechanisms, low solubility in blood, a low renal clearance rate, and various metabolites and other yet defined effects on skin. The enigma of the purported efficacy of triamcinolone acetonide may lie in the fact that it has a unique nature of having a long-term effect on dermatologic disease using a seemingly low dose compared with other routes of administration and other corticosteroids. Possible reasons for this may be binding differences at the intramuscular site, low solubility due to acetonide esters, a slow rate of absorption from the injected site, and a low renal clearance rate. There is still much to be learned about its mechanism of action, which may be of clinical and therapeutic significance.
引用
收藏
页码:1189 / 1199
页数:11
相关论文
共 50 条
  • [41] Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema
    Androudi, S
    Letko, E
    Meniconi, M
    Papadaki, T
    Ahmed, M
    Foster, CS
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2005, 13 (2-3) : 205 - 212
  • [42] Efficacy of Suprachoroidal Triamcinolone Acetonide for Uveitic Cystoid Macular Edema
    Zhou, Avery
    Philip, Andrew
    Babiker, Fatima
    Chang, Peter
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [43] Efficacy of triamcinolone acetonide and bupivacaine for pain after lumbar discectomy
    Syah Bahari
    Mohamed El-Dahab
    May Cleary
    Joseph Sparkes
    European Spine Journal, 2010, 19 : 1099 - 1103
  • [44] Efficacy and retention times of intravitreal triamcinolone acetonide for macular edema
    Kogure, Akiko
    Ohkoshi, Kishiko
    Kogure, Shunsuke
    Yamaguchi, Tatsuo
    Kishi, Shoji
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2008, 52 (02) : 122 - 126
  • [45] Efficacy and retention times of intravitreal triamcinolone acetonide for macular edema
    Akiko Kogure
    Kishiko Ohkoshi
    Shunsuke Kogure
    Tatsuo Yamaguchi
    Shoji Kishi
    Japanese Journal of Ophthalmology, 2008, 52 : 122 - 126
  • [46] Pharmacotherapeutic efficacy of preservative-free intravitreal triamcinolone acetonide
    Kuo, Chih-Hung
    McCluskey, Peter
    Gillies, Mark
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (01) : 155 - 166
  • [47] RELATIVE EFFICACY OF FLUOCINOLONE ACETONIDE COMPARED WITH TRIAMCINOLONE ACETONIDE IN TREATMENT OF ORAL LICHEN-PLANUS
    THONGPRASOM, K
    LUANGJARMEKORN, L
    SERERAT, T
    TAWEESAP, W
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1992, 21 (10) : 456 - 458
  • [48] TOXICITY OF TRIAMCINOLONE ACETONIDE
    OPHIR, A
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1981, 92 (04) : 587 - 588
  • [49] Comparative evaluation of therapeutic efficacy and safety of intralesional triamcinolone acetonide injection vs intralesional radiofrequency with intralesional triamcinolone acetonide in treatment of keloids
    Kaushal, Vishw
    Kumar, Sumir
    Brar, Balwinder Kaur
    Singh, Amarbir
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [50] SUBCONJUNCTIVAL TRIAMCINOLONE ACETONIDE
    STURMAN, RM
    LAVAL, J
    STURMAN, MF
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1966, 61 (01) : 155 - &